Bioprosthetic Aortic Valve Thrombosis: Definitions, Clinical Impact, and Management: A State-of-the-Art Review-Reference-Cited by-同舟云学术

Bioprosthetic Aortic Valve Thrombosis: Definitions, Clinical Impact, and Management: A State-of-the-Art Review

Published:2024-07 Issue:7 Volume:17 Page:
ISSN:1941-7640
Container-title:Circulation: Cardiovascular Interventions
language:en
Short-container-title:Circ: Cardiovascular Interventions

Author:

Chitturi Kalyan R.¹^ORCID,Aladin Amer I.¹^ORCID,Braun Ryan²,Al-Qaraghuli Abdullah K.¹,Banerjee Avantika¹,Reddy Pavan¹^ORCID,Merdler Ilan¹,Chaturvedi Abhishek¹^ORCID,Abusnina Waiel¹,Haberman Dan¹,Lupu Lior¹,Rodriguez-Weisson Fernando J.¹,Case Brian C.¹^ORCID,Wermers Jason P.¹^ORCID,Ben-Dor Itsik¹,Satler Lowell F.¹,Waksman Ron¹^ORCID,Rogers Toby¹²^ORCID

Affiliation:

1. Section of Interventional Cardiology, MedStar Washington Hospital Center, DC (K.R.C., A.I.A., A.K.A.-Q., A.B., P.R., I.M., A.C., W.A., D.H., L.L., F.J.R.-W., B.C.C., J.P.W., I.B.-D., L.F.S., R.W., T.R.).

2. Cardiovascular Branch, Division of Intramural Research, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD (R.B., T.R.).

Abstract

Bioprosthetic aortic valve thrombosis is frequently detected after transcatheter and surgical aortic valve replacement due to advances in cardiac computed tomography angiography technology and standardized surveillance protocols in low-surgical-risk transcatheter aortic valve replacement trials. However, evidence is limited concerning whether subclinical leaflet thrombosis leads to clinical adverse events or premature structural valve deterioration. Furthermore, there may be net harm in the form of bleeding from aggressive antithrombotic treatment in patients with subclinical leaflet thrombosis. This review will discuss the incidence, mechanisms, diagnosis, and optimal management of bioprosthetic aortic valve thrombosis after transcatheter aortic valve replacement and bioprosthetic surgical aortic valve replacement.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference92 articles.

1. Hemodynamics and Subclinical Leaflet Thrombosis in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement

2. Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

3. Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study

4. Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves

5. Reduced Leaflet Motion in Bioprosthetic Aortic Valves — The FDA Perspective